Clinical Perspectives on Platinum Resistance
Top Cited Papers
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 59 (Supplement) , 9-17
- https://doi.org/10.2165/00003495-200059004-00002
Abstract
The platinum compounds cisplatin and carboplatin are widely used in the treatment of a number of solid malignancies. Although some platinum-sensitive tumours may be cured by combination chemotherapy...Keywords
This publication has 58 references indexed in Scilit:
- Clinical Pharmacokinetics and Administration of Established Platinum DrugsDrugs, 2000
- Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancerBone Marrow Transplantation, 1999
- Cellular and molecular determinants of cisplatin resistanceEuropean Journal Of Cancer, 1998
- hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agentsOncogene, 1997
- Relationship of LRP-human major vault protein toin vitro and clinical resistance to anticancer drugsCytotechnology, 1996
- Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Platinum resistance: Laboratory findings and clinical implicationsThe International Journal of Cell Cloning, 1993
- Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agentsInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1989
- Identification of new drugs in pretreated patients with small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1989